Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.

GlaxoSmithKline (GSK)

Status and phase: Completed; Phase 4

Conditions: Asthma

Treatments: Drug: Salmeterol/fluticasone propionate; Drug: Fluticasone propionate

Study type: Interventional

Funder types: Industry

Identifiers

NCT00169546

SAM40100

Details and patient eligibility

About

Comparison of two asthma treatments by lung function measures.

Enrollment: 64 patients

Sex: All

Ages: 4 to 11 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Currently receiving 200-800mcg/day beclomethasone dipropionate.
• sRAW value of 1.3 kPa's.

Exclusion criteria

• 3 or more courses of oral steroids in last 12 months.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

64 participants in 1 patient group

Arm 1

Experimental group

Treatment:

Drug: Fluticasone propionate

Drug: Salmeterol/fluticasone propionate